Androgens and estrogens in benign prostatic hyperplasia: Past, present and future
Differentiation2011Vol. 82(4-5), pp. 184–199
Citations Over TimeTop 10% of 2011 papers
Related Papers
- → Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.(1992)307 cited
- → The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia(1999)182 cited
- → Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair(2023)8 cited
- → Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase.(1991)132 cited
- → The role of dihydrotestosterone in benign prostatic hyperplasia(1992)2 cited